推荐产品
等級
certified reference material
pharmaceutical secondary standard
品質等級
API 家族
magnesium stearate
包裝
ampule of 2.5 g
應用
pharmaceutical (small molecule)
格式
neat
儲存溫度
2-30°C
一般說明
Magnesium stearate is commonly utilized as a lubricant in pharmaceutical formulations to avoid the excipient blend from the formulation contents from sticking to the manufacturing equipment.
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
應用
Magnesium stearate may be used as an excipient for the manufacturing of atorvastatin drug and poloxamers. The determination of the analyte in pharmaceutical formulations can be carried out by chromatography and colorimetric methods.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
分析報告
These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available.
其他說明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
腳註
To see an example of a Certificate of Analysis for this material enter LRAA1467 in the slot below. This is an example certificate only and may not be the lot that you receive.
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
nwg
閃點(°F)
Not applicable
閃點(°C)
Not applicable
Analysis of magnesium from magnesium stearate in pharmaceutical tablet formulations using hydrophilic interaction liquid chromatography with nano quantity analyte detection
Journal of Pharmaceutical and Biomedical Analysis, 78, 112-117 (2013)
Liquid chromatographic determination of atorvastatin in bulk drug, tablets, and human plasma
Journal of Liquid Chromatography and Related Technologies, 27(1), 83-93 (2004)
Quantitation of poloxamers in pharmaceutical formulations using size exclusion chromatography and colorimetric methods
Journal of Pharmaceutical and Biomedical Analysis, 35(5), 1127-1142 (2004)
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门